Expert consensus on the diagnosis and treatment of recurrent wheezing in preschool children

Abstract Background Wheezing is a very common symptom in preschool children. Compared with that of older children with wheezing or asthma, the morbidity and health care utilization of preschool are disproportionately high, imposing a heavy economic burden on the health care system and society. Furthermore, severe and frequent wheezing in early life is associated with a trajectory of poor lung function, which is associated with respiratory and non-respiratory health outcomes in later adulthood, including high-risk chronic obstructive pulmonary disease and high-risk cardiovascular and cerebrovascular events in middle age. However, recurrent preschool wheezing, which is defined as two or more wheezing episodes in children younger than 6 years, excluding bronchiolitis, is highly heterogeneous in etiology and prognosis and poses significant diagnostic and therapeutic challenges for pediatricians. Methods Thirty Chinese experts majoring in pediatric pulmonology and epidemiology were invited to write this practical consensus on the diagnosis and treatment of recurrent wheezing in preschool children on the basis of evidence collection and experience. Elucidation and reviews were conducted using electronic databases, including PubMed, Embase, Web of Science, Cochrane Library, China National Knowledge Infrastructure (CNKI), and Wanfang databases. We used variations in terms for “wheezing”, “asthma”, “wheezing bronchitis”, “preschool”, “children”, and “pediatric”. Results The etiology, evaluation, management of acute wheezing exacerbation, and strategy of long-term anti-inflammatory therapy in recurrent preschool wheezing are highlighted. The most common causes of preschool wheezing are virus-induced wheezing and asthma (typical wheezing), some of which require long-term anti-inflammatory therapy. Some other children had identifiable underlying diseases (atypical wheezing). On the basis of the confirmation of wheezing, the underlying diseases and phenotypes of typical wheezing should be carefully investigated. For acute wheezing, inhaled short-acting β₂-agonists are the first-line agents, and systemic corticosteroids should be reserved only for severe cases. Routine use of azithromycin is not recommended in acute wheezing. The decision to initiate long-term anti-inflammatory therapy for recurrent preschool wheezing should be based on a comprehensive evaluation of clinical risk indicators and treatable traits such as type 2 inflammation. Immunomodulators such as bacterial lysates may be considered for use in trials in preschool children with recurrent virus-induced wheezing. Conclusions This symptom-based, phenotype-oriented consensus provides practical guidance for the individualized management of heterogeneous recurrent wheezing in preschool children. Further studies are needed to identify clinical risk factors and biomarkers for persistent wheezing and asthma. More appropriate long-term treatment regimens should also be explored.

Authors

Institutions

Publication Details

Journal
World Journal of Pediatrics
Published
2026-11-17
DOI
https://doi.org/10.1007/s12519-026-01114-6
Primary Topic
Asthma and respiratory diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Expert consensus on the diagnosis and treatment of recurrent wheezing in preschool children

Deyu Zhao, Guannan Bai, 罗征秀, Gary Wong et al.
World Journal of Pediatrics
Asthma and respiratory diseases
article

Expert consensus on the diagnosis and treatment of recurrent wheezing in preschool children

Deyu Zhao, Guannan Bai, 罗征秀, Gary Wong, Lina Chen, Hanmin Liu, Hailin Zhang, Kunling Shen, Lan-Fang Tang, Chuangli Hao, Liu En-mei, Guo-hong Zhu, Man Tian, Dan Xu, Hong-Min Fu, Ying-Xue Zou, Xiao-Yan Dong, Shun-Ying Zhao, Yuan-Yuan Zhang, Quan Lu, Jian-Guo Hong, Ying-Shuo Wang, Zhi-Min Chen, Zhou Fu, Shu-Xian Li, Xiao-Bo Zhang, Xing Chen, Xiao-Xia Lu, Yun-Lian Zhou, Yong Yin
article en

Abstract

Abstract Background Wheezing is a very common symptom in preschool children. Compared with that of older children with wheezing or asthma, the morbidity and health care utilization of preschool are disproportionately high, imposing a heavy economic burden on the health care system and society. Furthermore, severe and frequent wheezing in early life is associated with a trajectory of poor lung function, which is associated with respiratory and non-respiratory health outcomes in later adulthood, including high-risk chronic obstructive pulmonary disease and high-risk cardiovascular and cerebrovascular events in middle age. However, recurrent preschool wheezing, which is defined as two or more wheezing episodes in children younger than 6 years, excluding bronchiolitis, is highly heterogeneous in etiology and prognosis and poses significant diagnostic and therapeutic challenges for pediatricians. Methods Thirty Chinese experts majoring in pediatric pulmonology and epidemiology were invited to write this practical consensus on the diagnosis and treatment of recurrent wheezing in preschool children on the basis of evidence collection and experience. Elucidation and reviews were conducted using electronic databases, including PubMed, Embase, Web of Science, Cochrane Library, China National Knowledge Infrastructure (CNKI), and Wanfang databases. We used variations in terms for “wheezing”, “asthma”, “wheezing bronchitis”, “preschool”, “children”, and “pediatric”. Results The etiology, evaluation, management of acute wheezing exacerbation, and strategy of long-term anti-inflammatory therapy in recurrent preschool wheezing are highlighted. The most common causes of preschool wheezing are virus-induced wheezing and asthma (typical wheezing), some of which require long-term anti-inflammatory therapy. Some other children had identifiable underlying diseases (atypical wheezing). On the basis of the confirmation of wheezing, the underlying diseases and phenotypes of typical wheezing should be carefully investigated. For acute wheezing, inhaled short-acting β₂-agonists are the first-line agents, and systemic corticosteroids should be reserved only for severe cases. Routine use of azithromycin is not recommended in acute wheezing. The decision to initiate long-term anti-inflammatory therapy for recurrent preschool wheezing should be based on a comprehensive evaluation of clinical risk indicators and treatable traits such as type 2 inflammation. Immunomodulators such as bacterial lysates may be considered for use in trials in preschool children with recurrent virus-induced wheezing. Conclusions This symptom-based, phenotype-oriented consensus provides practical guidance for the individualized management of heterogeneous recurrent wheezing in preschool children. Further studies are needed to identify clinical risk factors and biomarkers for persistent wheezing and asthma. More appropriate long-term treatment regimens should also be explored.

World Journal of Pediatrics
Chinese University of Hong Kong (HK), Shanghai Jiao Tong University (CN), Capital Medical University (CN), Sichuan University (CN), Wenzhou Medical University (CN), Soochow University (CN), West China Second University Hospital of Sichuan University (CN), Kunming Children's Hospital (CN), Shanghai Children's Medical Center (CN), Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University (CN), Children's Hospital of Zhejiang University (CN), Prince of Wales Hospital (CN), Tianjin Children's Hospital (CN), Shandong Provincial Hospital (CN), Shanghai First People's Hospital (CN), Second Affiliated Hospital of Nanjing Medical University (CN), Wuhan Children's Hospital (CN), Beijing Children’s Hospital (CN), Shenzhen Children's Hospital (CN), Children's Hospital of Fudan University (CN), Shanghai Children's Hospital (CN), Children's Hospital of Chongqing Medical University (CN), Shandong First Medical University (CN), Zhejiang University (CN)
Asthma and respiratory diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon